Management of a Pregnant Woman With Fibromuscular Dysplasia

Elena Berra¹, Anna F Dominiczak¹, Rhian M Touyz¹+8

• ¹From the Department of Cardiology, Cliniques Universitaires Saint-Luc (E.B., S.P., A.P.), Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique (S.P., A.P.), and Department of Radiology, Cliniques Universitaires Saint-Luc (F.H.), Université Catholique de Louvain, Brussels, Belgium; Internal Medicine and Hypertension Division, Department of Medical Sciences, AOU Città della Salute e della Scienza, Turin, Italy (E.B.); Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, United Kingdom (A.F.D., R.M.T.); Division of Internal Medicine and Hypertension Unit, Department of Medical Science, University of Padova, Italy (G.P.R.); Department of Hypertension, Hospital Italiano de Buenos Aires, Argentina (R.G.M.); Department of Hypertension, Instituto Cardiovascular Lezica, San Isidro, Argentina (R.G.M.); Abbott Argentina, Buenos Aires (R.G.M.); Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (J.A.S.); Hadassah-Hebrew University Medical Center, Mount-Scopus, Jerusalem, Israel (M.B.); and Division of Cardiovascular Medicine, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden (T.K.).+1